You Searched For "US approves Remdesivir" and got 17 results
Sort By:
Cipla, Zydus Cadila, Jubilant Life and Dr Reddy’s shares gain after FDA approves Remdesivir for treating COVID-19 patients
The shares of pharma major Cipla, Zydus Cadila, Jubilant Life Sciences and Dr Reddy Labs gained dur…
Gilead's remdesivir just got the first FDA approval to be used as a treatment for coronavirus patients
Gilead Sciences just received approval from the US Food and Drug Administration to use its antivira…
Allana Akhtar
US health authorities will allow emergency use of Gilead's coronavirus treatment
The coronavirus treatment just succeeded in a critical trial, helping severe COVID-19 patients reco…
Zachary Tracer,Andrew Dunn
US FDA approves emergency use of Remdesivir for COVID-19 patients
The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the e…
Remdesivir, the only antiviral authorized for COVID-19 in the US, did not improve chances of survival in a massive WHO study
Gilead's drug remdesivir, taken by President Donald Trump, didn't appear to stop COVID-19 patient d…
Kate Duffy
The US government's supply of remdesivir — the only drug proved to treat the coronavirus — is due to run out at the end of June
The number of US COVID-19 patients requiring remdesivir outnumbers available stocks by two to one, …
Bill Bostock
Gilead sold $873 million worth of its antiviral COVID-19 treatment even though data on its success remains mixed
Gilead posted its first numbers detailing how much money the pharmaceutical company has made throug…
Allana Akhtar
The federal government finally announced initial plans to distribute Gilead's coronavirus drug remdesivir after days of confusion
The government said it's distributing the promising coronavirus drug, remdesivir, to some hard-hit …
Anna Medaris Miller
COVID-19: Jubilant Life inks licensing agreement with Gilead for remdesivir
The EUA is based on available data from two global clinical trials -- US National Institute for Al…
PTI
Gilead rises after pricing its coronavirus-fighting drug remdesivir
"We believe that pricing remdesivir well below value is the right and responsible thing to do," sai…
Carmen Reinicke
Cipla to sell anti-viral drug remdesivir as Cipremi in India
In May, US drug maker Gilead Sciences extended a voluntary non-exclusive license to Cipla to man…
Cipla signs licensing agreement with Gilead to manufacture and sell antiviral drug remdesivir
Leading pharmaceutical company Cipla on Wednesday announced it has signed a non-exclusive licensing…
Remdesivir expected to be available for COVID-19 patients from next week: top company official
The Food and Drug Administration (FDA) gave emergency use authorisation (EUA) for the use of invest…
PTI
US secures almost entire world stock of Covid-19 drug remdesivir from Gilead Sciences for the next three months
As a result of an agreement with the drug maker announced earlier this week, the US Department …
US health authorities are reportedly preparing to allow emergency use of Gilead's antiviral remdesivir to treat coronavirus patients, following positive study results
FDA is reportedly preparing to allow emergency use of remdesivir as soon as today. The treatment he…
Andrew Dunn
The WHO will not recommend remdesivir for COVID-19 patients, since it doesn't seem to boost their chances of survival
In a statement on Thursday, the World Health Organization said it will not recommend remdesivir bec…
Susie Neilson
More than 20 COVID drugs identified to keep the virus from replicating
"Remdesivir has proven successful at shortening the recovery time for patients in the hospital…